Early Revascularization Bests Drug Therapy In Long-Term Survival After Acute MI
This article was originally published in The Gray Sheet
Executive Summary
Physically clearing a patient's arteries as soon as possible after a heart attack with cardiogenic shock is better for long-term survival than quickly stabilizing the patient with drugs, a study in the June 7 Journal of the American Medical Association concludes
You may also be interested in...
When Less Is More: Costly Interventions For ACS Patients Critiqued In JAMA
Acute myocardial infarction care in the U.S. could benefit from less of a focus on invasive cardiac interventions and more reliance on established, inexpensive medical management strategies, researchers suggest in the March 16 issue of JAMA
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.